Clinical Trials

Through our clinical trials program, the Section of Family Planning and Contraceptive Research conducts innovative research to increase the array of available contraceptive methods.

We conduct both sponsor- and investigator-initiated clinical trials with a particular interest in developing new contraceptive methods and understanding contraceptive uptake and adherence.

Our location at the University of Chicago, one of the nation’s premiere academic and research institutions, provides access to state-of-the-art medical and research facilities as well as a diverse participant population. The Section maintains a dedicated staff of research professionals that oversees every aspect of the clinical trial-from budget development to data collection-and provides for efficient and timely study implementation. By advancing knowledge in the field of family planning, we improve the health and quality of life of women of all races, cultures, and economic backgrounds.

Recent Trials

2010 – Present

Phase IIB clinical trial of ulipristal acetate (UPA) as continuous contraception

A randomized, double Blind comparative Study to assess the efficacy, safety, tolerability and inhibition of ovulation of two continuous regimens of oral daily 5 mg or 10mg of ulipristal acetate (UPA), versus a dose of 5.0 mg UPA for 24/4 days 

 

Phase III clinical trial of a levonorgestrel-releasing intrauterine device and Mirena®

A randomized, multi-center, open-label clinical trial assessing the safety and efficacy of a levonorgestrel-releasing intrauterine device (LNG20) in nulliparous and parous females of child-bearing potential who request long-term, reversible contraception.

#